Roger Grau

1.9k total citations
9 papers, 305 citations indexed

About

Roger Grau is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Roger Grau has authored 9 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Roger Grau's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Roger Grau is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Roger Grau collaborates with scholars based in Switzerland, Germany and United Kingdom. Roger Grau's co-authors include Christoph A. Klein, Claudia Hartmann, Martin Bezler, Jakob R. Izbicki, Uta Reichelt, Stefan B. Hosch, Paulus Schurr, Axel Ullrich, Wolfram Trudo Knoefel and Andreas Erbersdobler and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

Roger Grau

9 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger Grau Switzerland	6	167	104	84	84	66	9	305
Judith Atz Germany	10	205 1.2×	126 1.2×	66 0.8×	21 0.3×	83 1.3×	24	343
Natascha Rieder Switzerland	8	149 0.9×	97 0.9×	50 0.6×	34 0.4×	85 1.3×	17	359
Xi‐Zhao Li China	11	159 1.0×	133 1.3×	26 0.3×	69 0.8×	31 0.5×	26	320
J Black United States	7	64 0.4×	81 0.8×	28 0.3×	73 0.9×	157 2.4×	10	320
Heide Dierbach Germany	10	82 0.5×	142 1.4×	25 0.3×	61 0.7×	223 3.4×	10	413
Pia M. Challita-Eid United States	10	279 1.7×	142 1.4×	80 1.0×	59 0.7×	255 3.9×	18	556
Christophe Le Clorennec France	11	246 1.5×	171 1.6×	40 0.5×	47 0.6×	119 1.8×	17	392
Susanne Sprung Austria	12	221 1.3×	195 1.9×	19 0.2×	132 1.6×	91 1.4×	30	456
J. Zhang United States	8	160 1.0×	156 1.5×	37 0.4×	101 1.2×	39 0.6×	38	413
Fátima Vaz Portugal	7	91 0.5×	114 1.1×	20 0.2×	41 0.5×	34 0.5×	27	287

Countries citing papers authored by Roger Grau

Since Specialization

Citations

This map shows the geographic impact of Roger Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Grau more than expected).

Fields of papers citing papers by Roger Grau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Grau. The network helps show where Roger Grau may publish in the future.

Co-authorship network of co-authors of Roger Grau

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Grau. A scholar is included among the top collaborators of Roger Grau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Grau. Roger Grau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Popp, Simone L., Sabine Geisse, Roger Grau, et al.. (2014). Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a. Molecular Immunology. 63(2). 456–463. 43 indexed citations

Grau, Roger, et al.. (2011). Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies. Molecular Immunology. 48(12-13). 1512–1517. 30 indexed citations

Gerdes, Christian, Monika Patre, Valeria Nicolini, et al.. (2008). GA201, a novel humanized, glycoengineered EGFR antibody with enhanced ADCC and superior in vivo efficacy in xenograft models. Cancer Research. 68. 3973–3973. 3 indexed citations

Stoecklein, Nikolas H., Stefan B. Hosch, Martin Bezler, et al.. (2008). Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer. Cancer Cell. 13(5). 441–453. 162 indexed citations

Klein, Christian, Frank Herting, Thomas Friess, et al.. (2008). 504 POSTER GA101, a therapeutic glycoengineered CD20 antibody recognizing a type II epitope mediates outstanding anti-tumor efficacy in Non-Hodgkin lymphoma xenograft models and superior B cell depletion. European Journal of Cancer Supplements. 6(12). 160–160. 2 indexed citations

Umaña, Pablo, Ekkehard Moessner, Peter Bruenker, et al.. (2006). Novel 3rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction.. Blood. 108(11). 229–229. 44 indexed citations

Hawkins, Kristina C., Roger Grau, Dharmendra Kumar, et al.. (2005). Karyotypic analysis of adult pluripotent stem cells.. PubMed. 20(3). 769–84. 11 indexed citations

Dyer, Martin J.S., Samuel Moser, Peter Brünker, et al.. (2005). Enhanced Potency of Glycoengineered Anti-CD52 Monoclonal Antibodies (MAbs).. Blood. 106(11). 2958–2958. 4 indexed citations

Grau, Roger & Lutz Bachmann. (1997). The evolution of intergenic spacers of the 5S rDNA genes in the Drosophila obscura group: Are these sequences suitable for phylogenetic analyses?. Biochemical Systematics and Ecology. 25(2). 131–139. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact